Cafepharma Today

June 10 2025 - Novo Nordisk starts new CagriSema weightloss drug trial
Novo Nordisk starts new CagriSema weightloss drug trial
Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-up
A medical device trade war is brewing between the EU and China
Merck antibody drug for RSV approved by FDA
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Bristol to seek melanoma approval for Opdivo ahead of expectations
Yahoo/Reuters
Thursday, July 10, 2014 - 10:20am
tags:
Bristol-Myers Squibb, melanoma, Opdivo
[video] Allergan CEO comes out swinging
CNBC
Thursday, July 10, 2014 - 9:04am
tags:
Allergan, Pharma CEOs, M&A, Valeant Pharmaceuticals, David Pyott
Ocera Therapeutics Inc raises $25.2 mln public offering
Reuters
Thursday, July 10, 2014 - 8:59am
tags:
Ocera Therapeutics, stock offering, OCR-002
Will Curis (CRIS) Crush Estimates at Its Next Earnings Report?
Yahoo/Zacks.com
Thursday, July 10, 2014 - 8:58am
tags:
earnings, Curis
Cytokinetics announces additional results relating to Tirasemtiv
The Fly on the Wall
Thursday, July 10, 2014 - 8:55am
tags:
Cytokinetics, Tirasemtiv, Lou Gehrig's disease, amyotrophic lateral sclerosis
Latest Sarepta Study Update Shows Greater Decline in Walking Ability
TheStreet.com
Thursday, July 10, 2014 - 8:51am
tags:
Sarepta Therapeutics, eteplirsen, Duchenne Muscular Dystrophy
Pharma's Poor Reputation Doesn't Help In The Fight Against Superbugs
Forbes
Thursday, July 10, 2014 - 8:50am
tags:
superbugs, antibiotics, R&D
Biogen prices new, long-acting hemophilia med with eye on patient-switching
Fierce Pharma Marketing
Wednesday, July 9, 2014 - 5:15pm
tags:
Biogen Idec, hemophilia, patient-switching, Alprolix
Sanofi-Regeneron drug tames eczema in study
Yahoo/Reuters
Wednesday, July 9, 2014 - 5:09pm
tags:
Sanofi, Regeneron, eczema, atopic dermatitis, dupilumab
Salix Pharmaceuticals: ‘Better Deal Than It Is Being Viewed’
Barron's
Wednesday, July 9, 2014 - 4:59pm
tags:
Salix, Cosmo Pharma, M&A
Lung Cancer Genomic Mapping Yields New Targets in Study
Bloomberg
Wednesday, July 9, 2014 - 4:55pm
tags:
genomic mapping, lung cancer, Pfizer, Xalkori
GlaxoSmithKline: Fortifying Its Position In The Respiratory Segment
Seeking Alpha
Wednesday, July 9, 2014 - 3:08pm
tags:
GSK, asthma, Breo Ellipta
Judge tosses decade-old investor suit against Pfizer and Celebrex weeks before trial
Fierce Pharma
Wednesday, July 9, 2014 - 11:51am
tags:
Pfizer, Celebrex
Concert Pharmaceuticals' Shares Slip Despite Favorable FDA Meeting
Yahoo/Zacks.com
Wednesday, July 9, 2014 - 11:50am
tags:
Concert Pharmaceuticals, FDA, CTP-499, diabetic nephropathy
Actavis cans 190 Forest workers while 6 execs share up to $186M in deal 'awards'
Fierce Pharma
Wednesday, July 9, 2014 - 10:58am
tags:
Forest Labs, Actavis, layoffs
How Will Allergan (AGN) Stock React To New Restructuring Plan?
TheStreet.com
Wednesday, July 9, 2014 - 9:43am
tags:
Allergan, restructuring, Valeant Pharmaceuticals
Biotech Stock Roundup: Regado Plunges on Study Update, Jazz Gains on Product Acquisition Deal
Yahoo/Zacks.com
Wednesday, July 9, 2014 - 9:26am
tags:
Regado Biosciences, Jazz Pharmaceuticals, Regeneron, Sanofi, blinatumomab, Amgen, Defitelio
Celgene spondylitis drug misses main goal in late-stage study
Yahoo/Reuters
Wednesday, July 9, 2014 - 8:28am
tags:
Celgene, ankylosing spondylitis, Otezla
Allergan Said to Plan Cost Cuts Amid Valeant Defense
Bloomberg
Wednesday, July 9, 2014 - 8:11am
tags:
Allergan, Valeant Pharmaceuticals, restructuring, M&A
Salix to Merge With Cosmo in Latest Tax Inversion Deal
Bloomberg
Wednesday, July 9, 2014 - 8:03am
tags:
Salix, Cosmo Pharma, M&A, taxes

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.